Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT-Reference-Cited by-同舟云学术

Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

Published:2020-09-05 Issue:2 Volume:56 Page:481-491
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Giebel Sebastian^ORCID,Labopin Myriam^ORCID,Sobczyk-Kruszelnicka Malgorzata^ORCID,Stelljes Matthias,Byrne Jenny L.,Fegueux Nathalie,Beelen Dietrich W.,Rovira Montserrat,Spyridonidis Alexandros^ORCID,Blaise Didier^ORCID,Bornhäuser Martin,Karadogan Ihsan,Savani Bipin N.^ORCID,Nagler Arnon^ORCID,Mohty Mohamad,Martin Sonja,Chevallier Patrice,Neubauer Andreas,Damaj Gandhi,Koc Yener,Ganser Arnold,Collin Matthew,Yakoub-Agha Ibrahim,Ozdogu Hakan,Araujo Mercedes Colorado,Itäla-Remes Maija,Orchard Kim,Isaksson Cecilia,Bethge Wolfgang,Martin Hans,Aljurf Mahmoud,Faber Edgar,Caballero Dolores,Zák Pavel,Leleu Xavier,Bay Jacques-Olivier,Rohrlich Pierre-Simon,Kröger Nicolaus,Huynh Anne,Schäfer-Eckart Kerstin,Milpied Noel,Lenhoff Stig,Ho Aloysius,López Jose Luis Bello,Mordini Nicola,Lioure Bruno,Halaburda Kazimierz,Olivieri Attilio,Gedde-Dahl Tobias,Protheroe Rachel,Tischer Johanna,Klammer Matthias,Clausen Johannes,Potter Victoria,Ladetto Marco,Tilly Herve,Deconinck Eric,Brecht Arne,Müller Lutz Peter,Heinicke Thomas,Carrete Juan Pio Torres,Bazarbachi Ali,Reményi Péter,Rubio Marie Thérèse,Fanin Renato,Pérez-Simón Jose Antonio,Niels Murawski,Diez-Martin J. L.,Arat Mutlu,Hermine Olivier,Socié Gerard,Cornelissen Jan J.,Santarone Stella,Guyotat Denis,Bulabois Claude Eric,Bernasconi Paolo,Johansson Jan-Erik,Vrhovac Radovan,Greinix Hildegard,Lorenzo José Luis López,Apte Shashikant,Craddock Charles,Kobbe Guido,Zahrani Mohsen Al,Dreger Peter,Lange Andrzej,Tbakhi Abdelghani,Meijer Ellen,Llamas Carlos Vallejo,Santasusana Josep Maria Ribera,Corradini Paolo,Benedetti Fabio,Rambaldi Alessandro,Gandemer Virginie,Malfuson Jean-Valère,Kaare Ain,Risitano Antonio,Petrini Mario,Selleri Carmine,Wu Depei,

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-020-01050-7.pdf

Reference32 articles.

1. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628–33.

2. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15:367–9.

3. Blaise D, Maraninchi D, Archimbaud E, Reiffers J, Devergie A, Jouet JP, et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d’Etudes de la Greffe de Moelle Osseuse. Blood. 1992;79:2578–82.

4. Ringdén O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindeløv L, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood. 1994;83:2723–30.

5. Nagler A, Rocha V, Labopin M, Unal A, Ben Othman T, Campos A, et al. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen–a report from the acute leukemia working party of the European group for blood and marrow transplantation. J Clin Oncol. 2013;31:3549–56.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of reduced toxicity conditioning regimens between fludarabine plus melphalan and fludarabine plus busulfex in adult patients with acute lymphoblastic leukemia;Bone Marrow Transplantation;2024-07-12

2. Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients;Bone Marrow Transplantation;2024-05-03

3. Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1;Bone Marrow Transplantation;2024-03-04

4. Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1;2023-11-15

5. Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT;Bone Marrow Transplantation;2023-05-05